William C. Weldon
William C. Weldon is a prominent figure in the field of pharmacology and business administration. He served as the CEO and Chairman of Johnson & Johnson, a multinational corporation specializing in pharmaceuticals, medical devices, and consumer packaged goods.
Early Life and Education[edit]
William C. Weldon was born in Brooklyn, New York. He completed his Bachelor's degree in Biology from Quinnipiac University in Hamden, Connecticut.
Career[edit]
Weldon began his career at Johnson & Johnson in 1971, starting in the company's sales department. He held various positions within the company, including President of Ethicon Endo-Surgery and Company Group Chairman of Johnson & Johnson's pharmaceuticals group in North America.
In 2002, Weldon was appointed as the CEO of Johnson & Johnson, succeeding Ralph S. Larsen. During his tenure, he led the company through a period of significant growth and expansion. He also faced several challenges, including product recalls and legal issues.
In 2012, Weldon stepped down as CEO but continued to serve as Chairman until his retirement in December of the same year. He was succeeded by Alex Gorsky.
Legacy[edit]
Weldon's leadership at Johnson & Johnson is marked by his commitment to innovation and patient care. He is recognized for his efforts to expand the company's product portfolio and for his focus on addressing unmet medical needs.
Personal Life[edit]
Weldon is married and has two children. He is involved in various philanthropic activities, including serving on the board of trustees for his alma mater, Quinnipiac University.
See Also[edit]
External Links[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
